• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用诺拉外流泵抑制剂抑制外流泵

Inhibition of Efflux Pumps by Using NorA Efflux Pump Inhibitors.

作者信息

Rampacci Elisa, Felicetti Tommaso, Cernicchi Giada, Stefanetti Valentina, Sabatini Stefano, Passamonti Fabrizio

机构信息

Department of Veterinary Medicine, University of Perugia, Via San Costanzo 4, 06126 Perugia, Italy.

Department of Pharmaceutical Sciences, Via Del Liceo 1, 06123 Perugia, Italy.

出版信息

Antibiotics (Basel). 2023 Apr 24;12(5):806. doi: 10.3390/antibiotics12050806.

DOI:10.3390/antibiotics12050806
PMID:37237709
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10215160/
Abstract

One promising approach in treating antibiotic-resistant bacteria is to "break" resistances connected with antibacterial efflux by co-administering efflux pump inhibitors (EPIs) with antibiotics. Here, ten compounds, previously optimized to restore the susceptibility to ciprofloxacin (CIP) of -overexpressing , were evaluated for their ability to inhibit -mediated efflux in and synergize with CIP, ethidium bromide (EtBr), gentamycin (GEN), and chlorhexidine digluconate (CHX). We focused efforts on as a pathogenic bacterium of concern within veterinary and human medicine. By combining data from checkerboard assays and EtBr efflux inhibition experiments, the hits 2-arylquinoline , dihydropyridine and 2-phenyl-4-carboxy-quinoline were considered the best EPIs for . Overall, most of the compounds, except for 2-arylquinoline compound , were able to fully restore the susceptibility of to CIP and synergize with GEN as well, while the synergistic effect with CHX was less significant and often did not show a dose-dependent effect. These are valuable data for medicinal chemistry optimization of EPIs for and lay the foundation for further studies on successful EPIs to treat staphylococcal infections.

摘要

治疗耐抗生素细菌的一种有前景的方法是通过将外排泵抑制剂(EPI)与抗生素联合使用来“打破”与抗菌外排相关的耐药性。在此,对十种先前经过优化以恢复过表达菌株对环丙沙星(CIP)敏感性的化合物,评估了它们在菌株中抑制介导的外排以及与CIP、溴化乙锭(EtBr)、庆大霉素(GEN)和葡萄糖酸洗必泰(CHX)协同作用的能力。我们将重点放在作为兽医和人类医学中关注的病原菌的菌株上。通过结合棋盘法测定和EtBr外排抑制实验的数据,命中的2-芳基喹啉、二氢吡啶和2-苯基-4-羧基喹啉被认为是针对菌株的最佳EPI。总体而言,除2-芳基喹啉化合物外,大多数化合物能够完全恢复菌株对CIP的敏感性并与GEN协同作用,而与CHX的协同作用不太显著且通常不显示剂量依赖性效应。这些是用于菌株EPI药物化学优化的有价值数据,并为进一步研究成功治疗葡萄球菌感染的EPI奠定了基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47a0/10215160/3228d6c0ab70/antibiotics-12-00806-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47a0/10215160/751739a90cec/antibiotics-12-00806-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47a0/10215160/3228d6c0ab70/antibiotics-12-00806-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47a0/10215160/751739a90cec/antibiotics-12-00806-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47a0/10215160/3228d6c0ab70/antibiotics-12-00806-g002.jpg

相似文献

1
Inhibition of Efflux Pumps by Using NorA Efflux Pump Inhibitors.使用诺拉外流泵抑制剂抑制外流泵
Antibiotics (Basel). 2023 Apr 24;12(5):806. doi: 10.3390/antibiotics12050806.
2
Essential Oil, Extracts, and Sesquiterpenes Obtained From the Heartwood of Act as Potential Inhibitors of the NorA Multidrug Efflux Pump.从[植物名称]心材中获得的精油、提取物和倍半萜作为NorA多药外排泵的潜在抑制剂。 (注:原文中Act前缺少具体植物名称)
Front Microbiol. 2019 Feb 26;10:337. doi: 10.3389/fmicb.2019.00337. eCollection 2019.
3
New C-6 functionalized quinoline NorA inhibitors strongly synergize with ciprofloxacin against planktonic and biofilm growing resistant Staphylococcus aureus strains.新型 C-6 功能化喹啉 NorA 抑制剂与环丙沙星联用对浮游和生物膜生长的耐甲氧西林金黄色葡萄球菌菌株具有很强的协同作用。
Eur J Med Chem. 2022 Nov 5;241:114656. doi: 10.1016/j.ejmech.2022.114656. Epub 2022 Aug 6.
4
Repurposing Approved Drugs as Fluoroquinolone Potentiators to Overcome Efflux Pump Resistance in Staphylococcus aureus.将已批准药物再利用为氟喹诺酮增效剂,以克服金黄色葡萄球菌中的外排泵耐药性。
Microbiol Spectr. 2021 Dec 22;9(3):e0095121. doi: 10.1128/Spectrum.00951-21. Epub 2021 Dec 15.
5
Structural Modifications of the Quinolin-4-yloxy Core to Obtain New NorA Inhibitors.喹啉-4-氧基核心的结构修饰以获得新型 NorA 抑制剂。
Int J Mol Sci. 2020 Sep 24;21(19):7037. doi: 10.3390/ijms21197037.
6
Synthesis of amides from (E)-3-(1-chloro-3,4-dihydronaphthalen-2-yl)acrylic acid and substituted amino acid esters as NorA efflux pump inhibitors of Staphylococcus aureus.从(E)-3-(1-氯-3,4-二氢萘-2-基)丙烯酸和取代的氨基酸酯合成酰胺作为金黄色葡萄球菌的 NorA 外排泵抑制剂。
Bioorg Med Chem. 2019 Jan 15;27(2):343-353. doi: 10.1016/j.bmc.2018.12.008. Epub 2018 Dec 6.
7
Deciphering the Molecular Recognition Mechanism of Multidrug Resistance NorA Efflux Pump Using a Supervised Molecular Dynamics Approach.解析多药耐药 NorA 外排泵的分子识别机制:基于监督分子动力学方法。
Int J Mol Sci. 2019 Aug 19;20(16):4041. doi: 10.3390/ijms20164041.
8
From Quinoline to Quinazoline-Based S. aureus NorA Efflux Pump Inhibitors by Coupling a Focused Scaffold Hopping Approach and a Pharmacophore Search.从喹啉到基于喹唑啉的金黄色葡萄球菌 NorA 外排泵抑制剂:通过偶联聚焦的骨架跳跃方法和药效团搜索。
ChemMedChem. 2021 Oct 6;16(19):3044-3059. doi: 10.1002/cmdc.202100282. Epub 2021 Jun 26.
9
Efflux-mediated response of Staphylococcus aureus exposed to ethidium bromide.金黄色葡萄球菌对溴化乙锭的外排介导反应。
J Antimicrob Chemother. 2008 Sep;62(3):504-13. doi: 10.1093/jac/dkn217. Epub 2008 May 28.
10
Efflux pump inhibitory potential of indole derivatives as an arsenal against over-expressing .吲哚衍生物作为对抗过度表达的一种手段的外排泵抑制潜力
Microbiol Spectr. 2023 Sep 27;11(5):e0487622. doi: 10.1128/spectrum.04876-22.

引用本文的文献

1
Antimicrobial Strategies Proposed for the Treatment of and Other Dermato-Pathogenic spp. in Companion Animals: A Narrative Review.用于治疗伴侣动物皮肤致病性真菌及其他真菌的抗菌策略:一项叙述性综述
Vet Sci. 2024 Jul 11;11(7):311. doi: 10.3390/vetsci11070311.

本文引用的文献

1
Occurrence and Variability of the Efflux Pump Gene across the Genus.在 属中 外排泵基因的发生和变异性。
Int J Mol Sci. 2022 Dec 4;23(23):15306. doi: 10.3390/ijms232315306.
2
Increased Expression of Efflux Pump Drives the Rapid Evolutionary Trajectory from Tolerance to Resistance against Ciprofloxacin in Staphylococcus aureus.外排泵表达增加推动了金黄色葡萄球菌从耐受环丙沙星到耐药的快速进化轨迹。
Antimicrob Agents Chemother. 2022 Dec 20;66(12):e0059422. doi: 10.1128/aac.00594-22. Epub 2022 Nov 29.
3
Molecular mechanisms of antibiotic resistance revisited.
抗生素耐药性的分子机制再探讨。
Nat Rev Microbiol. 2023 May;21(5):280-295. doi: 10.1038/s41579-022-00820-y. Epub 2022 Nov 21.
4
Efflux-linked accelerated evolution of antibiotic resistance at a population edge.耐药性在种群边缘的外排相关加速进化。
Mol Cell. 2022 Nov 17;82(22):4368-4385.e6. doi: 10.1016/j.molcel.2022.10.024.
5
Drug efflux transporters in Staphylococcus pseudintermedius: in silico prediction and characterization of resistance.金黄色葡萄球菌中药物外排转运蛋白:耐药性的计算机预测和特征分析。
J Antimicrob Chemother. 2022 Nov 28;77(12):3283-3290. doi: 10.1093/jac/dkac314.
6
Antibiotic Resistance in Bacteria-A Review.细菌中的抗生素耐药性——综述
Antibiotics (Basel). 2022 Aug 9;11(8):1079. doi: 10.3390/antibiotics11081079.
7
Structural basis for inhibition of the drug efflux pump NorA from Staphylococcus aureus.金黄色葡萄球菌药物外排泵 NorA 抑制作用的结构基础。
Nat Chem Biol. 2022 Jul;18(7):706-712. doi: 10.1038/s41589-022-00994-9. Epub 2022 Mar 31.
8
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.2019 年全球细菌对抗菌药物耐药性的负担:系统分析。
Lancet. 2022 Feb 12;399(10325):629-655. doi: 10.1016/S0140-6736(21)02724-0. Epub 2022 Jan 19.
9
Microbial Efflux Pump Inhibitors: A Journey around Quinoline and Indole Derivatives.微生物外排泵抑制剂:喹啉和吲哚衍生物的探索之旅。
Molecules. 2021 Nov 19;26(22):6996. doi: 10.3390/molecules26226996.
10
Towards the sustainable discovery and development of new antibiotics.迈向新型抗生素的可持续发现与开发。
Nat Rev Chem. 2021;5(10):726-749. doi: 10.1038/s41570-021-00313-1. Epub 2021 Aug 19.